Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

bioAffinity, Pictor Collaborate on Asthma and COPD Tests

The collaboration will combine flow cytometry and proteomic analysis to help ID specific inflammatory pathways for chronic lung diseases.

Chronic Pulmonary Disorders

Chronic Rhinosinusitis Balloon Begins Trial

A US study is evaluating a drug-coated balloon designed to improve outcomes for chronic rhinosinusitis patients undergoing sinus surgery.

Chronic Pulmonary Disorders

Alpha-1 Antitrypsin Deficiency Drug Enters Ph3 Trial

Grifols enrolled the first patient in its Phase 3 SWIFT-SC clinical trial to evaluate its subcutaneous Alpha1-Proteinase Inhibitor for the treatment of alpha1-antitrypsin (AAT) deficiency.

Asthma

Asthma Attacks May Permanently Alter Airway Tissues

Research using lung-on-a-chip technology shows that mechanical stress from asthma attacks causes tissue damage independently of inflammation.

COPD

COPD Patients Need More Education on Wildfire Smoke Risks

New research suggests COPD patients lack critical information and clinical guidance to manage respiratory risks during wildfire events.

Cystic fibrosis

CFTR Modulator Use Linked to Lower Anxiety in Children and Parents

New research suggests cystic fibrosis transmembrane conductance regulator (CFTR) modulators may provide mental health benefits for pediatric patients and their caregivers early in treatment.

Pulmonary Fibrosis

Nebulized Treprostinil Preserved IPF Lung Function

Phase 3 trial results show significant reductions in clinical worsening and acute exacerbations for patients with idiopathic pulmonary fibrosis (IPF).

Allergies

Microplastics May Intensify Immune Response to Common Allergens

New research suggests that microplastic particles can bind to allergens and carry them deeper into the respiratory system.

Other Chronic Diseases

Comorbid Bronchiectasis + Diabetes Tied to Worse Outcomes

A large-scale international study found that comorbid bronchiectasis and diabetes is associated with higher mortality, increased hospitalizations, and more frequent exacerbations.